Life Sciences & Health Innovation

Belgium has long been a global biopharma leader, punching far above its size and offering direct access to Europe’s largest markets. At the heart of this success, Wallonia stands out as a vibrant region where biotech, engineering, and health innovation converge with industrial excellence.

Belgium’s ranking in Europe

  • #1

    for biotech aggregated market cap

  • #1

    biopharma R&D spending

  • #2

    for clinical trials

  • #3

    for biopharma export

1. PWC 2024 ; 2. Pharma.be 2025 – all rankings in EU per capita, except ranking in export which is absolute.

Belgium accounts for just 2.7% of Europe’s population, yet it stands among the continent’s top performers in biopharma.

There’s a good chance your medicines and vaccines come from Belgium

Belgium stands among the world’s biopharma powerhouses, representing 13% of EU’s biopharma exports. It leads Europe in biopharmaceutical R&D investment per capita—around €16 million every day—and ranks first for biotech market capitalisation, close to €50 billion.

The active presence of global pharma leaders have made Belgium a central hub for innovation, production, and exports in medicines and vaccines worldwide.

In Wallonia

  • 50k

    direct and indirect jobs in life sciences

  • #1

    export industry of the region

  • 5

    universities and 11.000 researchers

  • 4

    life sciences hubs

Wallonia, a mature life sciences & health ecosystem

Home to 300+ life sciences companies and sustained annual growth of 4.5%, Wallonia combines research excellence with industrial scale.

A recognized leader in biomanufacturing and nuclear medicine, the region exports advanced drug-substance production and radiopharma technologies to hospitals worldwide. Its fully integrated ecosystem — five universities, leading research centres, hospitals and specialized science parks — ensures a seamless path from discovery to commercialization.

With 100,000 m² (1.08 million sq ft) of ready-to-use lab space, CEIV Pharma-certified logistics, specialized supply chains and tailored funding and talent pipelines, Wallonia offers the ideal environment to transform innovation into global impact.

Our partners

Biowin
Support to Innovation

BioWin

The Health cluster of Wallonia, accelerating Belgian health-tech & biopharma innovation

Wallonie Entreprendre
Financing

Wallonie Entreprendre

The Regional public investor, with a Life
Sciences specialized team

B2H
Incubation, labs and offices

Bridge to Health

B2H connects entrepreneurs to all the valuable resources and skills of the Liège life sciences ecosystem

Biopark
Incubation, labs and offices

BioPark Charleroi

A unique life sciences hub to start, connect, grow, and shape the future of health

Success stories

Find out more
Article

Allegro chooses LégiaPark to expand its operations

16.02.2026
Find out more
Article

UCB invests in its Braine-l’Alleud site

16.02.2026
Find out more
Article

Mestastop Solutions establishes its European subsidiary at the Gosselies Biopark

09.02.2026
Find out more
Article

Hillgene chooses Wallonia for its European cell therapy operations

09.02.2026
Find out more
Article

HEPHAISTOS-Pharma sets up in Wallonia to revolutionise immunotherapies

09.02.2026
Find out more
Article

Samabriva sets up its industrial plant molecular farming unit in Wallonia

08.02.2026
Find out more
Article

AbolerIS Pharma established at the Gosselies BioPark

06.02.2026
Find out more
Article

Telix values Wallonia’s “Radiopharmacy Valley”

31.01.2026
Find out more
Article

Takeda present in Wallonia for more than 50 years

30.01.2026
Find out more
Article

Wallonia at the heart of Q1 Scientific’s development programme

28.01.2026